This is why I was so happy to partner with Congresswoman Suzan DelBene to reintroduce the Expanding Support for Living Donors Act, which strengthens and modernizes the Living Organ Donation Reimbursement Program by extending it through 2037. This way we can expand eligibility and increase reimbursement amounts beginning in fiscal year 2027.
Reauthorize the Living Organ Donation Reimbursement Program through 2037, expand eligibility, and increase reimbursement amounts for living organ donors.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
Rep. Miller said the bill would strengthen and modernize the Living Organ Donation Reimbursement Program by extending it through 2037, expanding eligibility, and increasing reimbursement amounts beginning in fiscal year 2027; the release also says the maximum reimbursement would rise to $10,000, pegged to inflation.
legacy_unverified · Source version not recorded · locator unknown
GovInfo lists H.R. 7868 as an introduced House bill, with Carol D. Miller as a cosponsor, referred on March 9, 2026 to the House Energy and Commerce and Ways and Means Committees. The introduced text would amend the Living Organ Donation Reimbursement Program by raising donor reimbursement to $10,000 for FY2027, expanding income eligibility, and authorizing funding through FY2037.
legacy_unverified · Source version not recorded · locator unknown
The NLDAC FAQ says the National Living Donor Assistance Center is funded by HRSA and that the maximum reimbursement for qualifying expenses during the donation process remains $6,000. It also says priority is given to donors whose household income is within 350% of HHS Poverty Guidelines if funding is insufficient.
Assessments
Miller was an original cosponsor and publicly promoted H.R. 7868 in March 2026, which closely matched the promise by proposing LODRP reauthorization through FY2037, broader eligibility, and a reimbursement increase to $10,000 indexed to inflation. However, official bill status remains introduction and committee referral, with no enactment or implementation. A separate HOLD Act enacted in February 2026 expanded some eligibility rules, but it did not deliver the promised full package and was not shown to be materially advanced by Miller. Because Miller made a serious federal legislative attempt but the promised outcome has not been delivered, this is not fulfilled, with effort credit.
Miller materially advanced the promise by reintroducing bipartisan legislation on March 18, 2026 that specifically would reauthorize the Living Organ Donation Reimbursement Program through 2037, expand eligibility, and raise reimbursement levels. But the available record here shows only introduction and advocacy, not enactment, implementation, or completed program changes. Under the federal office standard, that is a serious legislative attempt without delivery of the promised outcome, so the claim is best scored as never with effort credit.